Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MENINGOCOCCAL INFECTION”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07252804
What this trial is testing

Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Autoimmune Rheumatologic Disease
University of Sao Paulo General Hospital 263
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Large-scale testing (Phase 3)UnknownNCT04689165
What this trial is testing

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis, Meningococcal
Wei Cun 1,280
Early research (Phase 1)Study completedNCT00631995
What this trial is testing

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 360
Large-scale testing (Phase 3)Study completedNCT01214837
What this trial is testing

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 751
Not applicableLooking for participantsNCT07768163
What this trial is testing

Learn About the Safety of PENBRAYA During Pregnancy

Who this might be right for
Meningococcal Disease
Pfizer 50
Large-scale testing (Phase 3)Study completedNCT00464815
What this trial is testing

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,025
Testing effectiveness (Phase 2)UnknownNCT02919293
What this trial is testing

Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 360
Not applicableUnknownNCT04594785
What this trial is testing

Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection

Who this might be right for
Streptococcus PneumoniaStreptococcus Pyogenes InfectionNeisseria Meningitides Meningitis
University Hospital, Montpellier 150
Large-scale testing (Phase 3)Study completedNCT00496015
What this trial is testing

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 750
Testing effectiveness (Phase 2)Study completedNCT00471081
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 385
Large-scale testing (Phase 3)Study completedNCT01547715
What this trial is testing

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India

Who this might be right for
Bacterial Meningitis
Novartis 180
Not applicableStudy completedNCT07824076
What this trial is testing

Impact of an e-Bug Educational Intervention on HPV and Meningococcal ACWY Vaccine Uptake in Middle School Students

Who this might be right for
Meningococcal ACWY VaccinesHPV CoverageMeningitidis Infections+1 more
Centre Hospitalier Universitaire de Nice 53,608
Large-scale testing (Phase 3)Looking for participantsNCT07505836
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 1,040
Large-scale testing (Phase 3)Study completedNCT00463437
What this trial is testing

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Who this might be right for
Hepatitis BAcellular PertussisTetanus+3 more
GlaxoSmithKline 1,437
Large-scale testing (Phase 3)Study completedNCT00422292
What this trial is testing

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,664
Testing effectiveness (Phase 2)UnknownNCT06337071
What this trial is testing

The ACYW135 Meningococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. 1,200
Testing effectiveness (Phase 2)Study completedNCT02640404
What this trial is testing

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 224
Post-approval studies (Phase 4)Looking for participantsNCT06832514
What this trial is testing

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

Who this might be right for
Meningococcal Meningitis, Serogroup BTransgender PersonsSex Differences in Immune Response+1 more
University Ghent 250
Early research (Phase 1)Looking for participantsNCT07203755
What this trial is testing

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Who this might be right for
Diphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection
CanSino Biologics Inc. 260
Next Page